Jeffrey Bluestone

All filings by Jeffrey Bluestone on record concern Gilead Sciences, Inc., in the capacity of senior executive. We count 18 filings; the first trade dates from 8 December 2021 and the latest from 20 August 2026.

Every open-market trade on record is a sale: 6 sales worth €1.1M. Other entries cover 1 share grant and 11 option exercises. In 2026 alone, the filings show no purchases and 5 sales.

Most recently, on 21 August 2026, the filings show an open-market sale worth €207k in Gilead Sciences, Inc. Typically, a trade is published a median of 1 day after it takes place. For comparison, the SEC allows two business days to file a Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.